Niva Bupa Health Insurance Company Limited (NIVABUPA)

Loading page…

Niva Bupa Health Insurance Company Limited (NIVABUPA) · mywealthgrid

About

Niva Bupa Health Insurance Company Limited operates in General Insurance within the Financials sector. Market cap stands at ₹15,285 Cr with latest quarterly revenue of ₹2,077.66 Cr (Mar 2026), having recently recovered to ₹345.13 Cr profit after a three-quarter loss cycle.

Face value: ₹10

Market cap

₹13,485 Cr

P/E

103.1×

P/B

3.5×

Dividend yield

ROE

3.4%

ROCE

—

Debt / equity

—

OPM

—

EPS (TTM)

₹0.7

Book value

₹20.6

52-week high

—

52-week low

—

Key insights

Company research notes and source-linked reviews

Key risks

Profitability volatility: Three consecutive quarterly losses (Dec 2025: -₹87.64 Cr, Sep 2025: -₹35.27 Cr, Jun 2025: -₹91.44 Cr) reversed by ₹345.13 Cr profit in Mar 2026. Researcher should verify cause and sustainability of recovery.
Low profitability: ROE of 3.45% is weak for insurance; researcher should obtain underwriting profit margins and loss ratios to assess whether core operations are profitable or masked by investment income.
High valuation multiple: PE of 116.88 prices in strong future earnings growth. Verify if ₹2,078 Cr revenue run-rate is sustainable and whether company can grow to justify this multiple.
Operational opacity: OPM and D/E not disclosed; researcher should obtain underwriting profit, expense ratios, and capital structure to assess true profitability and leverage.

Generated analysis · source review pending

Growth drivers

Revenue acceleration: ₹1,308.42 Cr (Jun 2025) to ₹2,077.66 Cr (Mar 2026) shows 58.7% growth; researcher should verify if sustainable or reflects seasonal/quarterly volatility
Profitability recovery: ₹345.13 Cr net profit in Mar 2026 reverses prior losses; verify if underwriting improved, investment gains contributed, or one-time factors drove recovery
Earnings capacity: ROE of 3.45% paired with PE of 116.88 indicates market expects margin expansion; researcher should verify if company can achieve higher normalized profitability as revenue base grows

Generated analysis · source review pending

461 historical price candles were omitted because the exchange source has not been verified.

₹73.0-0.4%1Y

Quick read

rule-based

Pros

No positive flags triggered.

Cons

−Low return on equity of 4.6% (3-yr avg)
−Expensive at 103.1× trailing earnings

Research score

Structured signal from quality, growth, valuation and momentum.

42/100

Business quality: 0
Growth: 100
Valuation: 26

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY MICROCAP 250 NIFTY TOTAL MARKET

Screen this industry

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore

₹ Cr	Mar 2025	Mar 2026
	5,324	6,474
Operating expenses	—	—
Operating profit (EBITDA)	—	—
OPM %	—	—
Depreciation	—	—
Interest	—	—
Other income	—	—
Profit before tax	214	127
Tax	0	-4
Tax %	0%	-3.1%
	214	131
PAT margin %	4%	2%
EPS (₹)	1.2	0.7
EPS adjusted (₹)	1.2	0.7
Annual report	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2025	Mar 2026
Equity capital	1,827	1,847
Reserves	1,950	1,959
Borrowings	—	—
Other liabilities	—	—
Total equity & liabilities	—	—
Fixed assets	75	88
CWIP	—	—
Investments	8,175	9,670
Other assets	—	—
Total assets	3,308	3,452

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: 22%

Compounded profit growth

7 years: —
5 years: —
3 years: —
1 year: -39%

Return on equity

7 years: —
5 years: —
3 years: —
Last year: 3%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2025	Mar 2026
Margins
Gross margin %	—	—
EBITDA margin %	—	—
EBIT margin %	—	—
PAT margin %	4%	2%
Working capital
Receivable days	—	—
Inventory days	—	—
Payable days	—	—
NWC days	—	—
Leverage
Current ratio	—	—
Debt to EBITDA	—	—
Debt to equity	—	—
Interest coverage	—	—
Asset turnover	1.61	1.88
Return ratios
Return on assets %	6.5%	3.8%
Return on capital employed %	—	—
Return on equity %	5.7%	3.4%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	55.98%	55.98%	55.98%	55.43%	55.41%	55.36%	55.36%	55.3%
	8.63%	8.85%	8.9%	10.76%	10.72%	10.32%	10.6%	12.09%
	9.57%	9.83%	9.7%	15.06%	15.31%	16.04%	16.49%	16.17%
Government	0%	0%	0%	0%	0%	0%	0%	0%
	25.82%	25.34%	25.42%	18.75%	18.56%	18.28%	17.55%	16.44%
No. of shareholders	—	—	—	—	1,58,550	1,47,718	1,35,343	1,26,567

Promoter holding down 0.68 percentage points since Sep 2024.

25 deals · 2 Jun 2025 – 15 Jun 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
15 Jun 2026	KRISHNAN RAMACHANDRAN	Block	BSE	Sell	40,00,000	₹83.00	₹33.20 Cr
15 Jun 2026	HSBC GLOBAL INVESTMENT FUNDS INDIAN EQUITY	Block	BSE	Buy	21,35,355	₹83.00	₹17.72 Cr
15 Jun 2026	HSBC INDIEN	Block	BSE	Buy	13,13,743	₹83.00	₹10.90 Cr
15 Jun 2026	HSBC INDIAN EQUITY MOTHER FUND	Block	BSE	Buy	5,50,902	₹83.00	₹4.57 Cr
2 Jun 2025	FETTLE TONE LLP	Bulk	BSE	Sell	9,14,63,415	₹82.11	₹751.01 Cr
2 Jun 2025	FETTLE TONE LLP	Bulk	BSE	Sell	8,14,63,414	₹82.76	₹674.19 Cr
2 Jun 2025	SBI MUTUAL FUND	Bulk	BSE	Buy	1,51,72,318	₹82.00	₹124.41 Cr
2 Jun 2025	DSP MUTUAL FUND	Bulk	BSE	Buy	1,40,18,374	₹82.00	₹114.95 Cr
2 Jun 2025	M PALLONJI AND CO PVT LTD	Bulk	NSE	Buy	1,35,60,000	₹83.95	₹113.84 Cr
2 Jun 2025	DSP MUTUAL FUND	Bulk	BSE	Buy	1,34,62,422	₹82.00	₹110.39 Cr

1–10 of 25

1 / 3

Mr. Ashwani BhatiaNon-Executive - Independent Director-Chairperson
Mr. Vipul SharmaChief Risk Officer
Mr. Krishnan RamachandranExecutive Director-CEO-MD
Ms. Geeta Dutta GoelNon-Executive - Independent Director
Mr. Mohit GuptaNon-Executive - Independent Director
Mr. Vivek Anant KarveNon-Executive - Independent Director
Mr. David Martin FletcherNon-Executive - Non Independent Director
Mr. Roger William John DavisNon-Executive - Non Independent Director
Mr. Vishwanath MahendraExecutive Director
Mr. Ankur KharbandaExecutive Director
Mr. Christopher Patrick CarrollNon-Executive - Non Independent Director

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 10 fund houses

Held by these funds

8.61%

of the company's equity

All mutual funds

9.35%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

35 schemes · 10 fund houses

		Shares
Multi Cap FundNEW	Nippon India Mutual Fund	5.11 Cr	414.85	0.74%	2.763%	—
Small Cap Fund	Axis Mutual Fund	2.59 Cr	210.85	0.67%	1.404%	-0
Small Cap Fund	DSP Mutual Fund	1.75 Cr	142.41	0.66%	0.948%	-0
ELSS Tax Saver Fund	SBI Mutual Fund	1.61 Cr	130.82	0.41%	0.871%	-0
BALANCED ADVANTAGE FUNDNEW	Tata Mutual Fund	1.25 Cr	101.25	1.19%	0.674%	—
Banking And Financial Services Fund	SBI Mutual Fund	91 L	73.95	0.68%	0.492%	-0
BUSINESS CYCLE FUND	Tata Mutual Fund	77.71 L	63.15	2.43%	0.421%	+8.11 L
Flexi Cap Fund	DSP Mutual Fund	63.09 L	51.27	0.41%	0.341%	-0

1–8 of 35

1 / 5

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Jul 2026Transcript AI Summary PPT REC
May 2026Transcript AI Summary PPT

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results30 Jul 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

26 announcementsExport CSV

30 Sept 2026, 3:18 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

17 Sept 2026, 10:49 pmCompany Update

Announcement under Regulation 30 (LODR)-Credit Rating

Credit Rating PDF

16 Sept 2026, 5:32 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

16 Sept 2026, 12:07 pmCompany Update

Niva Bupa Health Insurance Company Limited Has Informed The Exchange About General Updates - ESG Rating

General PDF

26 Aug 2026, 10:14 pmCompany Update

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of ESOP / ESPS PDF

20 Aug 2026, 8:46 pmCompany Update

Announcement under Regulation 30 (LODR)-Credit Rating

Credit Rating PDF

20 Aug 2026, 3:27 pmCompany Update

Receipt Of Order From The Insurance Regulatory And Development Authority Of India (''IRDAI'')

General PDF

13 Aug 2026, 5:47 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

Date	Category	Subject	Filing
30 Sept 2026, 3:18 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
17 Sept 2026, 10:49 pm	Company Update Credit Rating	Announcement under Regulation 30 (LODR)-Credit Rating	PDF

Loading announcements…

Ratio	Mar 2025	Mar 2026
Margins
Gross margin %	—	—
EBITDA margin %	—	—
EBIT margin %	—	—
PAT margin %	4%	2%
Working capital
Receivable days	—	—
Inventory days	—	—
Payable days	—	—
NWC days	—	—
Leverage
Current ratio	—	—
Debt to EBITDA	—	—
Debt to equity	—	—
Interest coverage	—	—
Asset turnover	1.61	1.88
Return ratios
Return on assets %	6.5%	3.8%
Return on capital employed %	—	—
Return on equity %	5.7%	3.4%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Icici Lombard General Insurance Company LimitedICICIGIICICIGI	₹78,041 Cr	—	₹26,625 Cr	₹0 Cr	—	₹2,428 Cr	10.7%	—	17.8%	—
General Insurance Corporation Of IndiaGICREGICRE	₹56,825 Cr	—	₹49,141 Cr	₹0 Cr	—	₹8,901 Cr	19.6%	—	17.9%	—
Star Health And Allied Insurance Company LimitedSTARHEALTHSTARHEALTH	₹31,649 Cr	—	₹17,371 Cr	₹0 Cr	—	₹557 Cr	3.2%	—	7.6%	—
The New India Assurance Company LimitedNIACLNIACL	₹26,403 Cr	—	₹46,909 Cr	₹0 Cr	—	₹717 Cr	2.9%	—	5.7%	—
Go Digit General Insurance LimitedGODIGITGODIGIT	₹23,697 Cr	—	₹10,377 Cr	₹0 Cr	—	₹492 Cr	5.3%	—	12.1%	—
Niva Bupa Health Insurance Company LimitedNIVABUPANIVABUPA	₹13,485 Cr	—	₹6,474 Cr	₹0 Cr	—	₹131 Cr	2%	—	3.4%	—

Niva Bupa Health Insurance Company Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Events

Board meetings1

Announcements

Ratio timeline

Not in the F&O segment

Board meetings1

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Profit & loss

Balance sheet

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

1